GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Enterprise Value

Biogena Group Invest AG (WBO:BIO) Enterprise Value : €8.28 Mil (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biogena Group Invest AG's Enterprise Value is €8.28 Mil. Biogena Group Invest AG's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil. Therefore, Biogena Group Invest AG's EV-to-EBIT ratio for today is 47.02.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Biogena Group Invest AG's Enterprise Value is €8.28 Mil. Biogena Group Invest AG's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil. Therefore, Biogena Group Invest AG's EV-to-EBITDA ratio for today is 47.02.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Biogena Group Invest AG's Enterprise Value is €8.28 Mil. Biogena Group Invest AG's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was €0.17 Mil. Therefore, Biogena Group Invest AG's EV-to-Revenue ratio for today is 49.86.


Biogena Group Invest AG Enterprise Value Historical Data

The historical data trend for Biogena Group Invest AG's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Enterprise Value Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Enterprise Value
8.39 11.47 11.71 7.40

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Enterprise Value 8.39 11.47 11.71 7.40

Competitive Comparison of Biogena Group Invest AG's Enterprise Value

For the Packaged Foods subindustry, Biogena Group Invest AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Enterprise Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Enterprise Value falls into.



Biogena Group Invest AG Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Biogena Group Invest AG's Enterprise Value for the fiscal year that ended in Jan. 2024 is calculated as

Biogena Group Invest AG's Enterprise Value for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Biogena Group Invest AG's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=8.276/0.176
=47.02

Biogena Group Invest AG's current Enterprise Value is €8.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biogena Group Invest AG's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Biogena Group Invest AG's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=8.276/0.176
=47.02

Biogena Group Invest AG's current Enterprise Value is €8.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biogena Group Invest AG's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was €0.18 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Biogena Group Invest AG's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8.276/0.166
=49.86

Biogena Group Invest AG's current Enterprise Value is €8.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Biogena Group Invest AG's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was €0.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG Enterprise Value Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.

Biogena Group Invest AG (WBO:BIO) Headlines